<p>Disease tolerance is a defence strategy essential for survival of infections, limiting physiological damage without killing the pathogen<sup><CitationRef CitationID="CR1">1</CitationRef>,<CitationRef CitationID="CR2">2</CitationRef></sup>. The disease course and pathology an infection may cause can change over the lifespan of a host due to the structural and functional physiological changes that accumulate with age. Because successful disease tolerance responses require the host to engage mechanisms that are compatible with the disease course and pathology caused by an infection, we predicted that this defence strategy would change with age. Animals infected with a 50%&#xa0;lethal dose &#xa0;(LD<sub>50</sub>)&#xa0;of a pathogen often show distinct health and sickness trajectories due to differences in disease tolerance<sup><CitationRef CitationID="CR1">1</CitationRef>,<CitationRef CitationID="CR3">3</CitationRef></sup> and can be used to define tolerance mechanisms. Here, using a polymicrobial sepsis model, we found that, despite having the same LD<sub>50</sub>, aged and young susceptible mice showed distinct disease courses. In young survivors, cardiac <i>Foxo1</i> and its downstream effector <i>Trim63</i> (MuRF1) protected from sepsis-induced cardiac remodelling, multi-organ injury and mortality. Conversely, in aged hosts, <i>Foxo1</i> and <i>Trim63</i> acted as drivers of sepsis pathogenesis and death. Our findings have implications for the tailoring of therapy to the age of an infected individual and indicate that disease tolerance genes show antagonistic pleiotropy.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Disease tolerance and infection pathogenesis age-related tradeoffs in mice

  • Karina K. Sanchez,
  • Justin L. McCarville,
  • Sarah J. Stengel,
  • Jessica M. Snyder,
  • April E. Williams,
  • Janelle S. Ayres

摘要

Disease tolerance is a defence strategy essential for survival of infections, limiting physiological damage without killing the pathogen1,2. The disease course and pathology an infection may cause can change over the lifespan of a host due to the structural and functional physiological changes that accumulate with age. Because successful disease tolerance responses require the host to engage mechanisms that are compatible with the disease course and pathology caused by an infection, we predicted that this defence strategy would change with age. Animals infected with a 50% lethal dose  (LD50) of a pathogen often show distinct health and sickness trajectories due to differences in disease tolerance1,3 and can be used to define tolerance mechanisms. Here, using a polymicrobial sepsis model, we found that, despite having the same LD50, aged and young susceptible mice showed distinct disease courses. In young survivors, cardiac Foxo1 and its downstream effector Trim63 (MuRF1) protected from sepsis-induced cardiac remodelling, multi-organ injury and mortality. Conversely, in aged hosts, Foxo1 and Trim63 acted as drivers of sepsis pathogenesis and death. Our findings have implications for the tailoring of therapy to the age of an infected individual and indicate that disease tolerance genes show antagonistic pleiotropy.